Skip to main content
Blood logoLink to Blood
. 2015 Aug 20;126(8):1048. doi: 10.1182/blood-2015-07-656918

Lee DW, Gardner R, Porter DL, et al. Current concepts in the diagnosis and management of cytokine release syndrome. Blood. 2014;124(2):188-195.

PMCID: PMC4543224

On page 192 in the 10 July 2014 issue, there are errors in Table 3. In the “Dose” column, the units for the doses of all vasopressors listed except dopamine should read “μg/min” rather than “μg/kg/min.” The corrected table is shown below. The error has been corrected in the online version, which now differs from the print version.

Table 3.

High-dose vasopressors (all doses are required for ≥3 hours)

Pressor Dose
Norepinephrine monotherapy ≥20 μg/min
Dopamine monotherapy ≥10 μg/kg/min
Phenylephrine monotherapy ≥200 μg/min
Epinephrine monotherapy ≥10 μg/min
If on vasopressin Vasopressin + norepinephrine equivalent of ≥10 μg/min*
If on combination vasopressors (not vasopressin) Norepinephrine equivalent of ≥20 μg/min*
*

VASST Trial vasopressor equivalent equation: norepinephrine equivalent dose = [norepinephrine (μg/min)] + [dopamine (μg/kg/min) ÷ 2] + [epinephrine (μg/min)] + [phenylephrine (μg/min) ÷ 10].


Articles from Blood are provided here courtesy of The American Society of Hematology

RESOURCES